كل ما تود معرفته عن Alzheimer | مجلة المجلة

ع

LATEST ISSUE

Latest Issue

النسخة العربية

FILE - This Oct. 7, 2003 file photo shows a closeup of a human brain affected by Alzheimer's disease, on display at the Museum of Neuroanatomy at the University at Buffalo in Buffalo, N.Y. An experimental Alzheimer’s drug modestly slowed the brain disease’s inevitable worsening, researchers reported Tuesday, Nov. 29, 2022 - and the next question is how much difference that might make in people’s lives. Japanese drugmaker Eisai and its U.S. partner Biogen had announced earlier this fall that the drug lecanemab appeared to work, a badly needed bright spot after repeated disappointments in the quest for better Alzheimer’s treatments. (AP Photo/David Duprey)

Drug Slows Alzheimer’s But Can It Make A Real Difference?

An experimental Alzheimer’s drug modestly slowed the brain disease’s inevitable worsening — but the anxiously awaited new data leaves unclear how much difference that might make in people’s lives. …

AP 30 November 2022

An Alzheimer's patient rests on a bench after a walk at the Village Landais Alzheimer site in Dax, France, September 24, 2020. Picture taken on September 24, 2020. REUTERS/Gonzalo Fuentes

Alzheimer's Drug Study Yields Positive Results, Say Makers Eisai and Biogen

An experimental Alzheimer's drug made by Eisai Co Ltd and Biogen slowed cognitive and functional decline in a large trial of patients in the early stages of the disease, they said on Tuesday,…

28 September 2022

The Food and Drug Administration has approved the use of a drug to treat Alzheimer's disease. But multimodal therapies could be the best way to treat it.(TNS)

The key to Treating Alzheimer’s Disease May Not Be a Drug

My personal journey with Alzheimer’s began in 2005 when my wife, Valerie, received her diagnosis with this terrible disease, one that robs the afflicted of their minds and forces family and friends…

Leroy Hood 23 June 2021

Popular
Editor's Pick

Politics

Rivalry in the Horn of Africa

31 January 2026

Is the Red Sea moving toward an ordered space governed by capable states or toward a grey zone edging toward disorder? Read our February cover story to find out.

Al Majalla - London

Documents & Memoirs

How the US got the SDF to capitulate to Damascus

02 February 2026

Al Majalla publishes a full account of what transpired during negotiations, the draft integration framework, and proposed constitutional amendments

Politics

Trump's only Iran option

03 February 2026

Ahead of US-Iran talks on Friday, Al Majalla lays out what's on the negotiating table and what issues Tehran is likely—and unlikely—to be flexible on

Incoming US President Donald Trump shakes hands with Indian Prime Minister Narendra Modi during a meeting in New Delhi, on 25 February 2020.

Business & Economy

What we know about the India-US trade deal

03 February 2026

Trump announced the deal in a social media post on Monday

Reuters/Al Majalla

Politics

The expiry of New START risks nuclear Armageddon

02 February 2026

A key nuclear limitation treaty between the US and Russia will expire on 5 February, leaving many biting their fingernails

OPINIONS

Why Saudi Arabia is against escalation with Iran

The strange loop of artificial creation

Emanuele Bottazzi Grifoni

Emanuele Bottazzi Grifoni

Libya after Saif al-Islam Gaddafi's assassination

Refaat Belkhair

Refaat Belkhair

Will the Epstein be the death of Trump's presidency?

0:00:00

0:00:00